Use of Veff and iso-NTCP in the implementation of dose escalation protocols
- PMID: 8226166
- DOI: 10.1016/0360-3016(93)90398-f
Use of Veff and iso-NTCP in the implementation of dose escalation protocols
Abstract
Purpose: This report investigates the use of a normal tissue complication probability (NTCP) model, 3-D dose distributions, and a dose volume histogram reduction scheme in the design and implementation of dose escalation protocols for irradiation of sites that are primarily limited by the dose to a normal tissue which exhibits a strong volume effect (e.g., lung, liver).
Methods and materials: Plots containing iso-NTCP contours are generated as a function of dose and partial volume using a parameterization of a NTCP description. Single step dose volume histograms are generated from 3-D dose distributions using the effective-volume (Veff) reduction scheme. In this scheme, the value of Veff for each dose volume histogram is independent of dose units (Gy, %). Thus, relative dose distributions (%) may be used to segregate patients by Veff into bins containing different ranges of Veff values before the assignment of prescription doses (Gy). The doses for each bin of Veff values can then be independently escalated between estimated complication levels (iso-NTCP contours).
Results and conclusion: Given that for the site under study, an investigator believes that the NTCP parameterization and the Veff methodology at least describe the general trend of clinical expectations, the concepts discussed allow the use of patient specific 3-D dose/volume information in the design and implementation of dose escalation studies. The result is a scheme with which useful prospective tolerance data may be systematically obtained for testing the different NTCP parameterizations and models.
Similar articles
-
Dose escalation for non-small cell lung cancer using conformal radiation therapy.Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1079-85. doi: 10.1016/s0360-3016(96)00593-7. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169816
-
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):724-35. doi: 10.1016/s0360-3016(02)03986-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573760
-
Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):156-62. doi: 10.1016/s0360-3016(02)02915-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182986
-
Partial irradiation of the liver.Semin Radiat Oncol. 2001 Jul;11(3):240-6. doi: 10.1053/srao.2001.23485. Semin Radiat Oncol. 2001. PMID: 11447581 Review.
-
Normal tissue radiosensitivity--how important is it?Clin Oncol (R Coll Radiol). 1996;8(1):25-34. doi: 10.1016/s0936-6555(05)80035-4. Clin Oncol (R Coll Radiol). 1996. PMID: 8688357 Review.
Cited by
-
The promise of dynamic contrast-enhanced imaging in radiation therapy.Semin Radiat Oncol. 2011 Apr;21(2):147-56. doi: 10.1016/j.semradonc.2010.11.001. Semin Radiat Oncol. 2011. PMID: 21356482 Free PMC article. Review.
-
Functional and molecular image guidance in radiotherapy treatment planning optimization.Semin Radiat Oncol. 2011 Apr;21(2):111-8. doi: 10.1016/j.semradonc.2010.10.002. Semin Radiat Oncol. 2011. PMID: 21356479 Free PMC article. Review.
-
Dosimetric comparison of extended dose range film with ionization measurements in water and lung equivalent heterogeneous media exposed to megavoltage photons.J Appl Clin Med Phys. 2003 Winter;4(1):25-39. doi: 10.1120/jacmp.v4i1.2539. J Appl Clin Med Phys. 2003. PMID: 12540816 Free PMC article.
-
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship.Radiother Oncol. 2017 Oct;125(1):66-72. doi: 10.1016/j.radonc.2017.09.005. Epub 2017 Sep 23. Radiother Oncol. 2017. PMID: 28947099 Free PMC article.
-
Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.Radiother Oncol. 2019 Sep;138:45-51. doi: 10.1016/j.radonc.2019.05.011. Epub 2019 May 27. Radiother Oncol. 2019. PMID: 31146070 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources